CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | EVNIN LUKE Director | Sale 10b5-1 | −40,761 | $0.65 | $26K | 2,413,158 |
| 2026-01-05 | EVNIN LUKE Director | Sale 10b5-1 | −18,378 | $0.64 | $12K | 2,453,919 |
| 2026-01-02 | EVNIN LUKE Director | Sale 10b5-1 | −18,568 | $0.63 | $12K | 2,472,297 |
| 2025-12-31 | EVNIN LUKE Director | Sale 10b5-1 | −24,962 | $0.62 | $15K | 2,490,865 |
| 2025-12-30 | EVNIN LUKE Director | Sale 10b5-1 | −34,847 | $0.61 | $21K | 2,515,827 |
| 2025-12-29 | EVNIN LUKE Director | Sale 10b5-1 | −108,606 | $0.61 | $66K | 2,550,674 |
| 2025-12-26 | EVNIN LUKE Director | Sale 10b5-1 | −35,632 | $0.63 | $22K | 2,659,280 |
| 2025-12-24 | EVNIN LUKE Director | Sale 10b5-1 | −16,310 | $0.65 | $11K | 2,694,912 |
| 2025-12-23 | EVNIN LUKE Director | Sale 10b5-1 | −71,428 | $0.63 | $45K | 2,711,222 |
| 2025-12-22 | EVNIN LUKE Director | Sale 10b5-1 | −59,307 | $0.69 | $41K | 2,782,650 |
| 2025-12-17 | EVNIN LUKE Director | Sale 10b5-1 | −9,983 | $1.14 | $11K | 2,841,957 |
| 2025-12-16 | EVNIN LUKE Director | Sale 10b5-1 | −14,548 | $1.05 | $15K | 2,851,940 |
| 2025-12-15 | EVNIN LUKE Director | Sale 10b5-1 | −23,640 | $1.07 | $25K | 2,866,488 |
| 2025-12-12 | EVNIN LUKE Director | Sale 10b5-1 | −17,858 | $1.08 | $19K | 2,890,128 |
| 2025-12-11 | EVNIN LUKE Director | Sale 10b5-1 | −28,009 | $1.07 | $30K | 2,907,986 |
| 2025-12-10 | EVNIN LUKE Director | Sale 10b5-1 | −37,104 | $1.06 | $39K | 2,935,995 |
| 2025-12-09 | EVNIN LUKE Director | Sale 10b5-1 | −44,570 | $1.01 | $45K | 2,973,099 |
| 2025-12-08 | EVNIN LUKE Director | Sale 10b5-1 | −34,041 | $0.99 | $34K | 3,017,669 |
| 2025-12-05 | EVNIN LUKE Director | Sale 10b5-1 | −16,568 | $0.97 | $16K | 3,051,710 |
| 2025-12-04 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale 10b5-1 | −83,230 | $0.97 | $81K | 4,784,111 |
Page 4 of 17 · 335 trades